Resumen de acción LIVN
LivaNova PLC, empresa de dispositivos médicos, diseña, desarrolla, fabrica y vende soluciones terapéuticas en todo el mundo.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Competidores de LivaNova PLC
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$55.53 |
| 52 Week High | US$59.86 |
| 52 Week Low | US$42.75 |
| Beta | 0.94 |
| 1 Month Change | -0.61% |
| 3 Month Change | 12.09% |
| 1 Year Change | 15.93% |
| 3 Year Change | -34.57% |
| 5 Year Change | -25.73% |
| Change since IPO | 362.75% |
Noticias y actualizaciones recientes
Recent updates
These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08
Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Jun 27LivaNova Matures Into Profitability, Still Waiting On DTD
May 10Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Apr 05LivaNova Continues To Be A Spring-Loaded Opportunity In Neuromodulation
Feb 11Is LivaNova PLC (NASDAQ:LIVN) Trading At A 35% Discount?
Jan 30At US$87.75, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Dec 29Does LivaNova (NASDAQ:LIVN) Have A Healthy Balance Sheet?
Nov 29Milan Court Decision Does Not Change LivaNova Bullish Story
Nov 16Rentabilidad de los accionistas
| LIVN | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 6.1% | 2.1% | 2.9% |
| 1Y | 15.9% | -1.9% | 22.2% |
Rentabilidad vs. Industria: LIVN superó al sector US Medical Equipment , que obtuvo un rendimiento del -0.5% el año pasado.
Rentabilidad vs. Mercado: LIVN obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| LIVN volatility | |
|---|---|
| LIVN Average Weekly Movement | 5.9% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: LIVN no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de LIVN (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2015 | 2,900 | Vladimir Makatsaria | www.livanova.com |
LivaNova PLC, empresa de dispositivos médicos, diseña, desarrolla, fabrica y vende soluciones terapéuticas en todo el mundo. La empresa opera a través de los segmentos Cardiopulmonar, Neuromodulación y Soporte Circulatorio Avanzado. El segmento Cardiopulmonar desarrolla, fabrica y vende productos cardiopulmonares, como oxigenadores, equipos de circulación extracorpórea, sistemas de autotransfusión, sistemas de tubos de perfusión, cánulas, conectores y otros productos relacionados.
Resumen de fundamentos de LivaNova PLC
| Estadísticas fundamentales de LIVN | |
|---|---|
| Capitalización bursátil | US$3.00b |
| Beneficios(TTM) | US$17.55m |
| Ingresos (TTM) | US$1.15b |
170.8x
Ratio precio-beneficio (PE)2.6x
Ratio precio-ventas (PS)¿Está LIVN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de LIVN | |
|---|---|
| Ingresos | US$1.15b |
| Coste de los ingresos | US$378.50m |
| Beneficio bruto | US$775.05m |
| Otros gastos | US$757.50m |
| Beneficios | US$17.55m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 01, 2024
| Beneficios por acción (BPA) | 0.33 |
| Margen bruto | 67.19% |
| Margen de beneficio neto | 1.52% |
| Ratio deuda/patrimonio | 45.9% |
¿Cómo se ha desempeñado LIVN a largo plazo?
Ver rendimiento histórico y comparativa